X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Aventis Pharma with Natco Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SANOFI INDIA vs NATCO PHARMA - Comparison Results

SANOFI INDIA    Change

Sanofi India (the erstwhile Aventis Pharma), the 60% subsidiary of Sanofi-Aventis SA, France, is one of the largest pharma MNCs in India with a turnover of over Rs 13.2 bn in CY11. Domestic sales constituted 81% of total sales in CY11 and exports con... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SANOFI INDIA NATCO PHARMA SANOFI INDIA/
NATCO PHARMA
 
P/E (TTM) x 34.3 19.6 175.3% View Chart
P/BV x 6.9 18.7 36.7% View Chart
Dividend Yield % 1.3 0.6 214.5%  

Financials

 SANOFI INDIA   NATCO PHARMA
EQUITY SHARE DATA
    SANOFI INDIA
Dec-16
NATCO PHARMA
Mar-14
SANOFI INDIA/
NATCO PHARMA
5-Yr Chart
Click to enlarge
High Rs4,560877 520.0%   
Low Rs4,400424 1,039.0%   
Sales per share (Unadj.) Rs1,028.5223.4 460.3%  
Earnings per share (Unadj.) Rs129.031.1 415.1%  
Cash flow per share (Unadj.) Rs186.040.3 461.8%  
Dividends per share (Unadj.) Rs68.005.00 1,360.0%  
Dividend yield (eoy) %1.50.8 197.4%  
Book value per share (Unadj.) Rs753.6219.5 343.3%  
Shares outstanding (eoy) m23.0333.07 69.6%   
Bonus/Rights/Conversions -PA-  
Price / Sales ratio x4.42.9 149.7%   
Avg P/E ratio x34.720.9 166.0%  
P/CF ratio (eoy) x24.116.1 149.2%  
Price / Book Value ratio x5.93.0 200.7%  
Dividend payout %52.716.1 327.6%   
Avg Mkt Cap Rs m103,17421,504 479.8%   
No. of employees `0003.6NA-   
Total wages/salary Rs m3,5921,128 318.5%   
Avg. sales/employee Rs Th6,537.7NM-  
Avg. wages/employee Rs Th991.4NM-  
Avg. net profit/employee Rs Th819.8NM-  
INCOME DATA
Net Sales Rs m23,6867,389 320.6%  
Other income Rs m708167 423.7%   
Total revenues Rs m24,3947,556 322.8%   
Gross profit Rs m5,2811,793 294.5%  
Depreciation Rs m1,313304 431.3%   
Interest Rs m15366 4.1%   
Profit before tax Rs m4,6611,290 361.4%   
Minority Interest Rs m046 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,691309 547.8%   
Profit after tax Rs m2,9701,027 289.1%  
Gross profit margin %22.324.3 91.9%  
Effective tax rate %36.323.9 151.6%   
Net profit margin %12.513.9 90.2%  
BALANCE SHEET DATA
Current assets Rs m15,6733,681 425.7%   
Current liabilities Rs m6,6783,123 213.8%   
Net working cap to sales %38.07.6 502.4%  
Current ratio x2.31.2 199.1%  
Inventory Days Days7689 84.9%  
Debtors Days Days2259 38.0%  
Net fixed assets Rs m8,0987,685 105.4%   
Share capital Rs m230331 69.6%   
"Free" reserves Rs m17,0886,670 256.2%   
Net worth Rs m17,3567,259 239.1%   
Long term debt Rs m0955 0.0%   
Total assets Rs m25,40011,957 212.4%  
Interest coverage x311.74.5 6,893.5%   
Debt to equity ratio x00.1 0.0%  
Sales to assets ratio x0.90.6 150.9%   
Return on assets %11.811.7 100.8%  
Return on equity %17.114.2 120.9%  
Return on capital %26.920.7 130.0%  
Exports to sales %24.539.4 62.2%   
Imports to sales %28.05.7 490.8%   
Exports (fob) Rs m5,8012,908 199.5%   
Imports (cif) Rs m6,627421 1,573.4%   
Fx inflow Rs m7,1453,445 207.4%   
Fx outflow Rs m6,846703 974.1%   
Net fx Rs m2992,743 10.9%   
CASH FLOW
From Operations Rs m3,2261,440 224.0%  
From Investments Rs m-1,555-1,089 142.8%  
From Financial Activity Rs m-1,818-353 515.5%  
Net Cashflow Rs m-147-1 9,865.8%  

Share Holding

Indian Promoters % 0.0 52.0 -  
Foreign collaborators % 60.4 1.5 4,108.8%  
Indian inst/Mut Fund % 14.4 7.8 183.7%  
FIIs % 14.6 16.6 87.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 10.5 26.0 40.4%  
Shareholders   15,184 25,395 59.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SANOFI INDIA With:   VENUS REMEDIES  ORCHID PHARMA LTD  NOVARTIS  J.B.CHEMICALS  SHASUN PHARMA  

Compare SANOFI INDIA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends Day up 260 Points; Pharma Stocks Top Gainers(Closing)

After opening the day in red, share markets in India witnessed positive trading activity throughout the day and ended the day on a positive note.

Related Views on News

NATCO PHARMA Announces Quarterly Results (4QFY18); Net Profit Up 69.6%

May 25, 2018 | Updated on May 25, 2018

For the quarter ended March 2018, NATCO PHARMA has posted a net profit of Rs 3 bn (up 69.6% YoY). Sales on the other hand came in at Rs 8 bn (up 32.9% YoY). Read on for a complete analysis of NATCO PHARMA's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

More Views on News

Most Popular

Alert: Pharma Stocks Are About to Shoot Up - And a Superb Stock for Trading(Profit Hunter)

Jun 13, 2018

The ailing pharma stocks are bouncing back to health. Read this to find out the best way to profit from them.

Will You Dump Your Client if You're Busy? Inox Wind's Auditor Just Did...(The 5 Minute Wrapup)

Jun 14, 2018

After Inox Wind, you may see more auditors resigning And the reasons can be as funny as they can get.

GST Will Not Solve Problem of High Prices of Petrol and Diesel(Vivek Kaul's Diary)

Jun 13, 2018

Though it will bring transparency in their pricing and that in itself will be a welcome move.

Should You Invest In Mirae Asset Healthcare Fund?(Outside View)

Jun 15, 2018

Mirae Asset Mutual Fund launches NFO - Mirae Asset Helathcare Fund.

Has the Market Bottomed Out?(Sector Info)

Jun 11, 2018

The yield spread is an effective barometer that can indicate the direction the markets are headed.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

SANOFI INDIA SHARE PRICE


Jun 22, 2018 (Close)

TRACK SANOFI INDIA

  • Track your investment in SANOFI INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SANOFI INDIA - SUN PHARMA COMPARISON

COMPARE SANOFI INDIA WITH

MARKET STATS